ArticleThe American journal of psychiatry2008
Cholinergic agonists as novel treatments for schizophrenia: the promise of rational drug development for psychiatry.
Article in The American journal of psychiatry, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed.
- Article
- Xanomeline-trospium (CobenfyClinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology · 2025Review
- Cross-ancestry genetic investigation of schizophrenia, cannabis use disorder, and tobacco smoking.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2024Article
- Imaging the Vesicular Acetylcholine Transporter in Schizophrenia: A Positron Emission Tomography Study Using [Biological psychiatry · 2024Article
- The New Horizon of Antipsychotics beyond the Classic Dopaminergic Hypothesis-The Case of the Xanomeline-Trospium Combination: A Systematic Review.Pharmaceuticals (Basel, Switzerland) · 2024Review
- Cross-ancestry genetic investigation of schizophrenia, cannabis use disorder, and tobacco smoking.medRxiv : the preprint server for health sciences · 2024Article
- Pauses in cholinergic interneuron firing exert an inhibitory control on striatal output in vivo.eLife · 2018Article
- Challenges in the development of an MBioorganic & medicinal chemistry letters · 2017Article
- Efficacy of Zinc Sulfate as an Add-on Therapy to Risperidone Versus Risperidone Alone in Patients With Schizophrenia: A Double-Blind Randomized Placebo-Controlled Trial.Iranian journal of psychiatry and behavioral sciences · 2015Article
- Sensory processing dysfunction in the personal experience and neuronal machinery of schizophrenia.The American journal of psychiatry · 2015Review
- Pharmacological Interventions for the MATRICS Cognitive Domains in Schizophrenia: What's the Evidence?Frontiers in psychiatry · 2013Review
- Allosteric modulation of the M1 muscarinic acetylcholine receptor: improving cognition and a potential treatment for schizophrenia and Alzheimer's disease.Drug discovery today · 2013Review
- Cholinergic contributions to the cognitive symptoms of schizophrenia and the viability of cholinergic treatments.Neuropharmacology · 2012Review
- Mouse pharmacological models of cognitive disruption relevant to schizophrenia.Neuropharmacology · 2012Review
- Pharmacologic treatment of first-episode schizophrenia: a review of the literature.The primary care companion for CNS disorders · 2012Article
- Regulation of cortical acetylcholine release: insights from in vivo microdialysis studies.Behavioural brain research · 2011Review
- Cognitive performance and smoking in first-episode psychosis: the self-medication hypothesis.European archives of psychiatry and clinical neuroscience · 2011Article
- The role of rodent models in the discovery of new treatments for schizophrenia: updating our strategy.Schizophrenia bulletin · 2010Review
- The antipsychotic potential of muscarinic allosteric modulation.Drug news & perspectives · 2010Review
- Nicotinic receptors: allosteric transitions and therapeutic targets in the nervous system.Nature reviews. Drug discovery · 2009Review
Corrections and comments
- Commented on by
- Comment on
- Comment on
Authors and funding
3 authors.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
18676593What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.